-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on Doximity, Raises Price Target to $40

Benzinga·11/06/2026 19:47:17
Listen to the news
Canaccord Genuity analyst Richard Close maintains Doximity (NYSE:DOCS) with a Buy and raises the price target from $36 to $40.